Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
SHANGHAI PECHEM
00338
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -0.16%2.48B | -4.84%11.73B | -6.41%7.9B | -4.50%5.53B | 0.56%2.49B | 3.88%12.33B | 5.61%8.44B | 6.64%5.79B | 7.04%2.47B | 8.58%11.87B |
| Operating income | -0.16%2.48B | -4.84%11.73B | -6.41%7.9B | -4.50%5.53B | 0.56%2.49B | 3.88%12.33B | 5.61%8.44B | 6.64%5.79B | 7.04%2.47B | 8.58%11.87B |
| Operating expenses | -0.12%-1.63B | 3.17%-7.56B | 5.47%-5.13B | 5.42%-3.37B | -0.25%-1.63B | -6.11%-7.8B | -6.01%-5.42B | -7.29%-3.56B | -4.06%-1.63B | -6.36%-7.35B |
| Gross profit | -0.71%849.78M | -7.72%4.18B | -8.10%2.77B | -3.02%2.16B | 1.18%855.86M | 0.23%4.53B | 4.90%3.01B | 5.61%2.23B | 13.28%845.89M | 12.40%4.52B |
| Selling expenses | -5.38%-277.72M | 3.89%-1.38B | 4.82%-928.26M | 2.34%-698.89M | -5.85%-263.54M | -2.59%-1.44B | -7.22%-975.23M | -8.33%-715.64M | -16.14%-248.97M | -15.78%-1.4B |
| Administrative expenses | 5.83%-336.9M | 2.91%-1.62B | 1.53%-1.1B | 0.07%-748.56M | -3.24%-357.75M | -3.43%-1.67B | -5.90%-1.11B | -4.36%-749.11M | -8.55%-346.52M | -15.42%-1.62B |
| Research and development expenses | -21.27%-7.84M | -27.29%-38.78M | -54.53%-20.88M | -50.68%-14.11M | -53.65%-6.46M | -52.47%-30.46M | -4.69%-13.51M | -8.02%-9.36M | -12.08%-4.21M | -41.03%-19.98M |
| Profit from asset sales | 299.25%386.35K | 4,286.31%72.6M | -38.55%884.24K | -115.45%-174.29K | -3,823.33%-193.9K | -23.97%1.66M | 156.14%1.44M | 321.40%1.13M | -87.88%5.21K | -94.62%2.18M |
| Revaluation surplus | -44.34%5.92M | 690.76%58.74M | 191.50%36.74M | 129.58%10.86M | 138.43%10.63M | 82.56%-9.94M | -246.84%-40.15M | -691.61%-36.71M | -772.30%-27.66M | 57.81%-57.01M |
| -Changes in the fair value of other assets | -44.34%5.92M | 690.76%58.74M | 191.50%36.74M | 129.58%10.86M | 138.43%10.63M | 82.56%-9.94M | -246.84%-40.15M | -691.61%-36.71M | -772.30%-27.66M | 57.81%-57.01M |
| Impairment and provision | 87.41%-996.59K | 55.43%-33.04M | 81.97%-17.61M | 111.07%7.42M | 75.28%-7.91M | 52.77%-74.13M | 30.12%-97.68M | 46.35%-67.06M | 29.54%-32.02M | 14.25%-156.95M |
| -Other impairment is provision | 87.41%-996.59K | 55.43%-33.04M | 81.97%-17.61M | 111.07%7.42M | 75.28%-7.91M | 52.77%-74.13M | 30.12%-97.68M | 46.35%-67.06M | 29.54%-32.02M | 14.25%-156.95M |
| Special items of operating profit | 106.08%19.74M | -5.38%271.88M | -21.85%166.65M | -1.61%150.34M | -56.55%9.58M | 96.82%287.33M | 44.97%213.26M | -3.25%152.8M | 41.38%22.05M | -27.89%145.98M |
| Operating profit | 4.50%244.31M | -5.43%1.45B | -7.72%883.09M | 8.36%841.2M | 16.06%233.79M | 11.58%1.53B | 8.39%956.98M | 4.62%776.27M | 12.52%201.43M | 8.18%1.38B |
| Financing income | -19.09%33.88M | -3.74%236.29M | 13.90%171.5M | -19.20%77.88M | -23.16%41.87M | -6.64%245.46M | 0.63%150.57M | 12.10%96.38M | 17.00%54.49M | 52.04%262.92M |
| Financing cost | 16.30%-3.31M | -18.67%-14.77M | -16.10%-11.37M | -16.41%-7.77M | -3.41%-3.95M | 30.40%-12.44M | 29.05%-9.8M | 28.48%-6.68M | 18.84%-3.82M | 14.79%-17.88M |
| Special items of earning before tax | -175.77%-2.7M | 22.76%-32.99M | 71.20%-5.8M | 77.62%-2.94M | 73.62%-980.23K | -3.50%-42.7M | -2.08%-20.13M | 6.06%-13.13M | 29.24%-3.72M | -18.31%-41.26M |
| Earning before tax | 0.68%271.41M | -4.21%1.64B | -2.91%1.04B | 6.98%907.47M | 9.71%269.57M | 9.32%1.71B | 7.76%1.07B | 5.83%848.27M | 14.81%245.72M | 13.29%1.56B |
| After-tax profit from continuing operations | 0.65%267.22M | 0.25%1.61B | 9.78%1.03B | 19.63%900.03M | 25.21%265.5M | -1.52%1.6B | -4.61%934.23M | -4.63%752.35M | 3.64%212.05M | 17.04%1.63B |
| Earning after tax | 0.65%267.22M | 0.25%1.61B | 9.78%1.03B | 19.63%900.03M | 25.21%265.5M | -1.52%1.6B | -4.61%934.23M | -4.63%752.35M | 3.64%212.05M | 17.04%1.63B |
| Minority profit | 78.23%10.04M | -33.24%39.26M | 13.64%48.92M | 18.95%43.49M | -2.17%5.63M | 19.51%58.81M | 10.57%43.05M | 36.66%36.56M | 15.84%5.76M | 1,004.83%49.2M |
| Profit attributable to shareholders | -1.03%257.18M | 1.53%1.57B | 9.60%976.71M | 19.66%856.54M | 25.97%259.86M | -2.17%1.54B | -5.24%891.18M | -6.08%715.79M | 3.33%206.29M | 13.06%1.58B |
| Basic earnings per share | 0.00%0.21 | 1.60%1.27 | 9.72%0.79 | 18.97%0.69 | 23.53%0.21 | -2.34%1.25 | -5.26%0.72 | -6.45%0.58 | 6.25%0.17 | 13.27%1.28 |
| Diluted earnings per share | 0.00%0.21 | 1.60%1.27 | 9.72%0.79 | 18.97%0.69 | 23.53%0.21 | -2.34%1.25 | -5.26%0.72 | -6.45%0.58 | 0.17 | 1.28 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | Deloitte Touche Tohmatsu会计师事务所 |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.